ES478717A1 - Procedimiento para la obtencion de lipopetidos. - Google Patents

Procedimiento para la obtencion de lipopetidos.

Info

Publication number
ES478717A1
ES478717A1 ES478717A ES478717A ES478717A1 ES 478717 A1 ES478717 A1 ES 478717A1 ES 478717 A ES478717 A ES 478717A ES 478717 A ES478717 A ES 478717A ES 478717 A1 ES478717 A1 ES 478717A1
Authority
ES
Spain
Prior art keywords
formula
amino acid
group
free
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES478717A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES478717A1 publication Critical patent/ES478717A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069Ser-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Procedimiento para la obtención de lipopéptidos de fórmula **fórmula** donde R1 y R2, en cada caso significan un resto hidrocarburo, saturado o insaturado, alifático, o mixto alifático-cicloalifático, en caso dado sustituido por funciones de oxígeno, con 11- 21 átomos de carbono, R3 significa hidrógeno o el resto R1-CO-O-CH2- donde R1 tiene el mismo significado y X es un amino-ácido alifático natural, peptídicamente enlazado, con carboxilo libre, esterificado o amidado, o una secuencia de aminoácidos de 2-10 aminoácidos alifáticos naturales, cuyo grupo carboxilo terminal se presenta en forma libre, esterificado o amidado o una secuencia de amino ácidos de 2-10 aminoácidos alifáticos naturales, en los cuales como mínimo la mitad llevan un grupo hidrófilo cuyo grupo carboxilo terminal se presenta en forma libre , esterificada o amidada, donde los centros de asimetría designados con * o bien ** tienen la configuración S absoluta o bien la configuración S o R y en caso dado, las mezclas de loscompuestos R y S epímeros en los átomos de C** y en caso dado las sales y los complejos, caracterizado porque un compuesto de fórmula: **fórmula** donde R1 y R2 y R3 tienen el significado indicado para la fórmula (I) y W significa OH o un aminoácido o una secuencia incompleta de aminoácidos según X en la fórmula (I) se hace reaccionar con un compuesto de fórmula NH2-Z1 (VIII) donde -NH-Z1 significa un grupo correspondiente al grupo X en la fórmula (I), o bien una secuencia de aminoácidos o bien aminoácido complementario al aminoácido mencionado o a la secuencia incompleta de aminoácidos según X, en cuya secuencia, sin embargo, no existen grupos amino libres, o una sal del mismo, y, si se desea en los compuestos obtenidos con grupo carboxilo terminal libre éste se transforma en un grupo amida o grupo éster y/o los compuestos se transforman en sus sales o complejos.
ES478717A 1977-06-20 1979-03-16 Procedimiento para la obtencion de lipopetidos. Expired ES478717A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77584 1977-06-20

Publications (1)

Publication Number Publication Date
ES478717A1 true ES478717A1 (es) 1979-12-16

Family

ID=19728618

Family Applications (3)

Application Number Title Priority Date Filing Date
ES470961A Expired ES470961A1 (es) 1977-06-20 1978-06-20 Procedimiento para la obtencion de lipopeptidos
ES478717A Expired ES478717A1 (es) 1977-06-20 1979-03-16 Procedimiento para la obtencion de lipopetidos.
ES478718A Expired ES478718A1 (es) 1977-06-20 1979-03-16 Procedimiento para la obtencion de lipopeptidos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES470961A Expired ES470961A1 (es) 1977-06-20 1978-06-20 Procedimiento para la obtencion de lipopeptidos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES478718A Expired ES478718A1 (es) 1977-06-20 1979-03-16 Procedimiento para la obtencion de lipopeptidos.

Country Status (18)

Country Link
EP (1) EP0000330B1 (es)
JP (2) JPS549224A (es)
AT (1) AT364095B (es)
AU (1) AU525005B2 (es)
CA (1) CA1139305A (es)
DD (1) DD139257A5 (es)
DE (1) DE2860893D1 (es)
DK (1) DK275178A (es)
ES (3) ES470961A1 (es)
FI (1) FI781933A7 (es)
GR (1) GR71681B (es)
IE (1) IE46957B1 (es)
IL (1) IL54950A (es)
NO (1) NO148921C (es)
NZ (1) NZ187611A (es)
PL (3) PL216739A1 (es)
PT (1) PT68188A (es)
ZA (1) ZA783504B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
EP0114787B1 (de) * 1983-01-25 1991-09-25 Ciba-Geigy Ag Neue Peptidderivate
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
FR2611205B1 (fr) * 1987-02-20 1990-03-02 Serbio Dipeptides, procede de preparation et utilisation dans le dosage de proteases
AU626797B2 (en) * 1987-09-08 1992-08-13 Albany Medical College Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
DE4119856A1 (de) * 1991-06-17 1992-12-24 Hoechst Ag N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
ES2096064T3 (es) * 1991-12-19 1997-03-01 Ciba Geigy Ag Derivados del acido aminosulfonico y procedimiento para su obtencion.
AU666789B2 (en) * 1992-12-28 1996-02-22 Takeda Chemical Industries Ltd. 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof
EP0604945A1 (en) * 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, its derivatives, production and use thereof
EP0641776A3 (en) * 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Thioglycerol derivatives.
GB9930591D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
DE10048840A1 (de) * 2000-10-02 2002-04-11 Biotechnolog Forschung Gmbh Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren
FR2816060A1 (fr) * 2000-10-27 2002-05-03 Pf Medicament Procede d'identification de nouvelles molecules se liant au recepteur lox et utilisation de ces molecules
KR101604799B1 (ko) 2005-06-13 2016-03-28 클리브랜드 바이오랩스, 아이엔씨. 리포펩티드를 사용하여 아폽토시스에 대항하는 보호방법
AU2006272647A1 (en) * 2005-07-25 2007-02-01 Therimunex Pharmaceuticals, Inc. Peptidyl diacylglycerides
DE102016005550B4 (de) 2016-05-09 2024-09-26 Hans-Georg Rammensee Adjuvans zur lnduzierung einer zellulären lmmunantwort
EP4365124A3 (en) * 2017-11-06 2024-08-07 Crown Equipment Corporation Industrial vehicle layover system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE785933A (fr) * 1971-07-07 1973-01-08 Ciba Geigy Procede de preparation de peptides contenant de la cystine
ZA735680B (en) * 1972-09-21 1974-07-31 Hoffmann La Roche Polypeptides
DE2706490A1 (de) 1976-02-20 1977-08-25 Ciba Geigy Ag Neue carbonsaeureester

Also Published As

Publication number Publication date
NO782138L (no) 1978-12-21
PT68188A (de) 1978-07-01
IE46957B1 (en) 1983-11-16
JPS6360760B2 (es) 1988-11-25
IL54950A (en) 1983-10-31
PL207766A1 (pl) 1979-11-19
IL54950A0 (en) 1978-08-31
AT364095B (de) 1981-09-25
JPS641466B2 (es) 1989-01-11
EP0000330B1 (de) 1981-08-05
FI781933A7 (fi) 1978-12-21
GR71681B (es) 1983-06-21
PL216739A1 (es) 1980-05-19
PL216740A1 (es) 1980-05-19
IE781227L (en) 1978-12-20
DK275178A (da) 1978-12-21
ZA783504B (en) 1979-06-27
AU525005B2 (en) 1982-10-14
DE2860893D1 (en) 1981-11-05
NZ187611A (en) 1981-07-13
ES478718A1 (es) 1979-12-16
EP0000330A1 (de) 1979-01-24
ATA445178A (de) 1981-02-15
AU3723078A (en) 1980-01-03
JPS549224A (en) 1979-01-24
NO148921C (no) 1984-01-11
DD139257A5 (de) 1979-12-19
JPS6372671A (ja) 1988-04-02
CA1139305A (en) 1983-01-11
ES470961A1 (es) 1980-03-01
NO148921B (no) 1983-10-03

Similar Documents

Publication Publication Date Title
ES478717A1 (es) Procedimiento para la obtencion de lipopetidos.
ES8406423A1 (es) Procedimiento para la preparacion de derivados de amino acidos, de efecto edulcorante
UY23635A1 (es) Procedimiento para la preparacion de conjugados del peg interferon
ES2194835T3 (es) Agentes antitromboticos a base de tripeptidos.
GB1494603A (en) N-(perfluoroalkanoyl)-n-phosphonomethyl glycine compounds
ES2036213T3 (es) Procedimiento para preparar derivados tetrahidroisoquinolin-1-ilicos de acidos carboxilicos.
JPS57212157A (en) Collagenase inhibitory compound
ES8706622A1 (es) Procedimiento para preparar alfa-aminoacidos sustituidos
ES304136A1 (es) Procedimiento para la preparacion de nuevas amidas n-sustituidas.
ES303014A1 (es) Procedimiento para la obtenciën de derivados de benzanilida
ATE26462T1 (de) Fluessige detergenszusammensetzung.
FR2411172A1 (fr) Procede pour la preparation de diesters d'acides dicarboxyliques
MX3330E (es) Procedimiento para la preparacion de 9-alcohilamino-eritromicinas y sus sales
ES2117132T3 (es) Sales de desferrioxamina-b y su uso como queladores de hierro eficaces por via oral.
ES2083387T3 (es) Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv.
ES2075976T3 (es) Derivados de aminoacido y su empleo como agentes antiviricos.
GB1199508A (en) Emollients comprising Novel Diester derived from Sterically Hindered Carboxylic Acids, and their preparation
ES471672A1 (es) Un procedimiento para la preparacion de un peptido
ES478204A1 (es) Un procedimiento para la preparacion de un peptido psicofar-macologicamente activo.
ES8302021A1 (es) Procedimiento para la preparacion de 3-0-desmenlistamicina b.
ES480762A1 (es) Procedimiento para la preparacion de derivados de cefem.
GR29903B (el) Μεθοδος δια την παρασκευην ενωσεων του δις-τριαζινυλαμινο-στιλβεντιου.
ES2095501T3 (es) Nuevos agentes yodados no ionicos de contraste a los rayos x, metodo para su preparacion y composiciones galenicas que los contienen.
ES2114698T3 (es) Procedimiento para la carbonilacion de compuestos acetilenicamente insaturados.
ES455532A1 (es) Procedimiento para la preparacion de triazapentadienos.